vaccineenterprise.org rank 219 |
Number of domains linking to vaccineenterprise.org 4 | semantic flow 0.35 |
Number of links to vaccineenterprise.org 5 | semantic flow 0.35 |
Number of domains linked from vaccineenterprise.org 4 | semantic flow 0.3 |
Number of links from vaccineenterprise.org 5 | semantic flow 0.3 |
Pages with highest topical PageRank pointing to domain.
url / atext / target url | |
---|---|
http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001616 http www vaccineenterprise org content prevention trials infants ↳http://www.vaccineenterprise.org/content/prevention-trials-infants | journals.plos.org |
http://www.vaccineenterprise.org/conference/2012/ about aids vaccine ↳http://www.vaccineenterprise.org/conference/2012/about-aids-vaccine | |
http://www.vaccineenterprise.org/conference/2012/ abstracts ↳http://www.vaccineenterprise.org/conference/2012/abstracts | |
http://www.vaccineenterprise.org/conference/2012/ print page print page ↳http://www.vaccineenterprise.org/conference/2012/print/archive-home-page |
On-topic pages from domain with highest topical PageRank.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
Novel Approaches to HIV Vaccine Research & Development | Global HIV Vaccine Enterprise http://www.vaccineenterprise.org/content/novel-approaches-hiv-vaccine-research-development | 0.28 | 1 | 38 | 9 | 2 | 1 | 0 | 0 | |
AIDS Vaccine 2012 Conference | Boston, USA | September 9-12, 2012 http://www.vaccineenterprise.org/conference/2012/ | 0.23 | 0.51 | 20 | 5 | 1 | 1 | 1 | 1 |
Relevant domains with most links to selected domain.
domain | |||
---|---|---|---|
http://typepad.com/ | 2 | 0.14 | typepad.com |
http://chavi.org/ | 1 | 0.08 | chavi.org |
http://hivresearch.org/ | 1 | 0.07 | hivresearch.org |
http://plos.org/ | 1 | 0.06 | plos.org |
Relevant domains with most links from selected domain.
domain | |||
---|---|---|---|
http://vaccineenterprise.com/ | 2 | 0.17 | vaccineenterprise.com |
http://plosmedicine.org/ | 1 | 0.08 | plosmedicine.org |
http://liebertonline.com/ | 1 | 0.03 | liebertonline.com |
http://flickr.com/ | 1 | 0.03 | flickr.com |
Pages from domain with most relevant inbound links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
http://www.vaccineenterprise.org/conference/2012/ | 2 | 0.23 | 0.99 | 0.17 | 0.51 | yes | 20 | 5 | 1 | 1 | 1 | 1 | |
http://www.vaccineenterprise.org/content/timely-topics-hiv-vaccines | 1 | 0.16 | 1 | 0.08 | 0.99 | yes | 58 | 18 | 2 | 1 | 0 | 0 | |
http://www.vaccineenterprise.org/timely-topics/new-technologies | 1 | 0.16 | 1 | 0.08 | 0.99 | yes | 64 | 19 | 2 | 1 | 0 | 0 | |
http://www.vaccineenterprise.org/content/aids-vaccine-conferences | 1 | 0.16 | 1 | 0.08 | 1 | yes | 35 | 8 | 2 | 1 | 0 | 0 | |
http://www.vaccineenterprise.org/content/nhp-webinar | 1 | 0.16 | 0.99 | 0.08 | 0.99 | yes | 47 | 14 | 2 | 1 | 0 | 0 | |
http://www.vaccineenterprise.org/conference/2011/ | 1 | 0.16 | 0.73 | 0.08 | 0.84 | yes | 21 | 6 | 1 | 1 | 1 | 1 | |
http://www.vaccineenterprise.org/envprotein/env-protein | 1 | 0.16 | 1 | 0.08 | 1 | yes | 39 | 8 | 2 | 1 | 0 | 0 | |
http://www.vaccineenterprise.org/content/host-genetics-and-hiv-diversity | 1 | 0.16 | 1 | 0.08 | 1 | yes | 38 | 9 | 2 | 1 | 0 | 0 | |
http://www.vaccineenterprise.org/user | 1 | 0.16 | 1 | 0.08 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.vaccineenterprise.org/ | 1 | 0.17 | 1 | 0.07 | 1 | yes | 43 | 10 | 2 | 1 | 1 | 1 |
Pages from domain with most likely on-topic outgoing links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
http://www.vaccineenterprise.org/ | 10 | 0.17 | 1 | 0.84 | 1 | yes | 43 | 10 | 2 | 1 | 1 | 1 | |
http://www.vaccineenterprise.org/content/timely-topics-hiv-vaccines | 9 | 0.16 | 1 | 0.69 | 0.99 | yes | 58 | 18 | 2 | 1 | 0 | 0 | |
http://www.vaccineenterprise.org/content/nhp-webinar | 6 | 0.16 | 0.99 | 0.48 | 0.99 | yes | 47 | 14 | 2 | 1 | 0 | 0 | |
http://www.vaccineenterprise.org/conference/2011/ | 5 | 0.16 | 0.73 | 0.22 | 0.84 | yes | 21 | 6 | 1 | 1 | 1 | 1 | |
http://www.vaccineenterprise.org/conference/2012/ | 4 | 0.23 | 0.99 | 0.1 | 0.51 | yes | 20 | 5 | 1 | 1 | 1 | 1 | |
http://www.vaccineenterprise.org/timely-topics/passive-immunization-trials-inform-hiv-vacc | 2 | 0.16 | 0.98 | 0.12 | 1 | yes | 63 | 20 | 2 | 1 | 0 | 0 | |
http://www.vaccineenterprise.org/content/host-genetics-and-hiv-diversity | 1 | 0.16 | 1 | 0.08 | 1 | yes | 38 | 9 | 2 | 1 | 0 | 0 | |
http://www.vaccineenterprise.org/timely-topics/how-complement-stimulates-b-cell-responses- | 1 | 0.16 | 0.98 | 0.08 | 1 | yes | 60 | 19 | 2 | 1 | 0 | 0 | |
http://www.vaccineenterprise.org/timely-topics/knowns-and-unknowns-assaying-adcc-against-h | 1 | 0.16 | 0.97 | 0.05 | 1 | yes | 59 | 19 | 2 | 1 | 0 | 0 | |
http://www.vaccineenterprise.org/timely-topics/new-technologies | 1 | 0.16 | 1 | 0.04 | 0.99 | yes | 64 | 19 | 2 | 1 | 0 | 0 |
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.